1993Journal of Antimicrobial ChemotherapyRequires access

Comparative susceptibility profile of piperacillin/tazobactam against anaerobic bacteria

Peter C. Appelbaum

Open publisher page 24 citations

Abstract

Current data are summarized on the comparative susceptibility of Gram-positive and Gram-negative anaerobic bacteria to piperacillin/tazobactam and other anti-anaerobe agents. For beta-lactamase-positive organisms, tazobactam, in fixed concentration or fixed ratio, lowered the MIC of piperacillin at least four-fold to susceptible levels in almost all cases; beta-lactamase-negative strains were all susceptible to piperacillin alone. Susceptibility rates and MIC90 values for piperacillin/tazobactam were comparable to those of other anti-anaerobe agents, including other combinations of beta-lactam agents with beta-lactamase inhibitors, such as amoxycillin/clavulanate, ticarcillin/clavulanate, ampicillin/sulbactam and cefoperazone/sulbactam. Kinetic studies revealed IC50 and Ki values for tazobactam that were in most cases lower than those of clavulanate and sulbactam against beta-lactamase-positive Gram-negative anaerobic bacilli.

About this research paper

What this paper is about

Current data are summarized on the comparative susceptibility of Gram-positive and Gram-negative anaerobic bacteria to piperacillin/tazobactam and other anti-anaerobe agents. For beta-lactamase-positive organisms, tazobactam, in fixed concentration or fixed ratio, lowered the MIC of piperacillin at least four-fold to susceptible levels in almost all cases; beta-lactamase-negative strains were all susceptible to piperacillin alone. Susceptibility rates and MIC90 values for piperacillin/tazobactam were comparable to those of other anti-anaerobe agents, including other combinations of beta-lactam agents with beta-lactamase inhibitors, such as amoxycillin/clavulanate, ticarcillin/clavulanate, ampicillin/sulbactam and cefoperazone/sulbactam. Kinetic studies revealed IC50 and Ki values for tazobactam that were in most cases lower than those of clavulanate and sulbactam against beta-lactamase-positive Gram-negative anaerobic bacilli.

Why it matters

OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Current data are summarized on the comparative susceptibility of Gram-positive and Gram-negative anaerobic bacteria to piperacillin/tazobactam and other anti-anaerobe agents. For beta-lactamase-positive organisms, tazobactam, in fixed concentration or fixed ratio, lowered the MIC of piperacillin at least four-fold to susceptible levels in almost all cases; beta-lactamase-negative strains were all susceptible to piperacillin alone. Susceptibility rates and MIC90 values for piperacillin/tazobactam were comparable to those of other anti-anaerobe agents, including other combinations of beta-lactam agents with beta-lactamase inhibitors, such as amoxycillin/clavulanate, ticarcillin/clavulanate, ampicillin/sulbactam and cefoperazone/sulbactam. Kinetic studies revealed IC50 and Ki values for tazobactam that were in most cases lower than those of clavulanate and sulbactam against beta-lactamase-positive Gram-negative anaerobic bacilli.

Key concepts: Sulbactam, Piperacillin, Tazobactam, Beta-Lactamase Inhibitors, Piperacillin/tazobactam, Microbiology, Ticarcillin, Anaerobic bacteria

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative susceptibility profile of piperacillin/tazobactam against anaerobic bacteria — Research Paper | ScholarLens